Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Thrombocythemia, Essential 1Sezary Syndrome 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pain 1Neurotoxicity Syndromes 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Liver Neoplasms 1Leukemia, Prolymphocytic 1Leukemia, Neutrophilic, Chronic 1

Interventions

Ipilimumab 3Triamcinolone Acetonide 2Ranibizumab 2Nivolumab 2Amplified Fragment Length Polymorphism Analysis 2treosulfan 1salicylhydroxamic acid 1aldesleukin 1Ultrasonography 1Tramadol 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Rose Bengal 1Radiosurgery 1Physical Examination 1Pharmacogenomic Testing 1Interviews as Topic 1Immunotherapy 1Ibuprofen 1Gemcitabine 1Eye Enucleation 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uveal Melanoma × Pharmacogenomic Testing × Clear all
NCT01217398 2013-08-26

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡